[Translation] A Phase I clinical study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and food effects of single and multiple ascending doses of LT-002-158 tablets in healthy adult subjects
本试验是LT-002-158片的首次人体(FIH)I期研究,旨在评价LT-002-158片在成年HV中单次口服给药(第一部分)、食物影响(第二部分)、多次口服给药(第三部分)后的安全性、PK和PD特征。
[Translation] This trial is a first-in-human (FIH) Phase I study of LT-002-158 tablets, designed to evaluate the safety, PK, and PD characteristics of LT-002-158 tablets in adult HVs after a single oral dose (Part I), food effects (Part II), and multiple oral doses (Part III).